Ipsogen's MapQuant Dx system enables pathologists, laboratories and oncologists to get a comprehensive view of tumor biology. Proprietary computation of the tumor expression profile allows the identification of key characteristics of the tumor and subsequently guides therapeutic decisions. This video clip illustrates how the system relates to breast cancer screening.